Fatema Z Chowdhury
Overview
Explore the profile of Fatema Z Chowdhury including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
16
Citations
1138
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Garcia-Broncano P, Maddali S, Einkauf K, Jiang C, Gao C, Chevalier J, et al.
Sci Transl Med
. 2019 Nov;
11(520).
PMID: 31776292
Neonatal HIV-1 infection is associated with rapidly progressive and frequently fatal immune deficiency if left untreated. Immediate institution of antiretroviral therapy (ART), ideally within hours after birth, may restrict irreversible...
2.
Kulkarni S, Lied A, Kulkarni V, Rucevic M, Martin M, Walker-Sperling V, et al.
Nat Immunol
. 2019 Sep;
20(11):1555.
PMID: 31548709
An amendment to this paper has been published and can be accessed via a link at the top of the paper.
3.
Kulkarni S, Lied A, Kulkarni V, Rucevic M, Martin M, Walker-Sperling V, et al.
Nat Immunol
. 2019 Jun;
20(7):824-834.
PMID: 31209403
Multiple genome-wide studies have identified associations between outcome of human immunodeficiency virus (HIV) infection and polymorphisms in and around the gene encoding the HIV co-receptor CCR5, but the functional basis...
4.
Einkauf K, Lee G, Gao C, Sharaf R, Sun X, Hua S, et al.
J Clin Invest
. 2019 Jan;
129(3):988-998.
PMID: 30688658
Chromosomal integration of genome-intact HIV-1 sequences into the host genome creates a reservoir of virally infected cells that persists throughout life, necessitating indefinite antiretroviral suppression therapy. During effective antiviral treatment,...
5.
Chowdhury F, Ouyang Z, Buzon M, Walker B, Lichterfeld M, Yu X
AIDS
. 2018 Oct;
32(18):2669-2677.
PMID: 30289807
Objective: Elite controllers, defined as persons maintaining undetectable levels of HIV-1 replication in the absence of antiretroviral therapy, represent living evidence that sustained, natural control of HIV-1 is possible, at...
6.
Orlova-Fink N, Chowdhury F, Sun X, Harrington S, Rosenberg E, Yu X, et al.
AIDS
. 2017 Sep;
31(16):2211-2215.
PMID: 28857825
Objective: The functional polarization of CD4 T cells determines their antimicrobial effector profile, but may also impact the susceptibility to infection with HIV-1. Here, we analyzed the susceptibility of CD4...
7.
Lee G, Orlova-Fink N, Einkauf K, Chowdhury F, Sun X, Harrington S, et al.
J Clin Invest
. 2017 Jun;
127(7):2689-2696.
PMID: 28628034
HIV-1 causes a chronic, incurable disease due to its persistence in CD4+ T cells that contain replication-competent provirus, but exhibit little or no active viral gene expression and effectively resist...
8.
Vigano S, Negron J, Tse S, Chowdhury F, Lichterfeld M, Yu X
AIDS
. 2016 Nov;
31(2):207-212.
PMID: 27835619
Objective(s): To assess the frequency and function of HIV-1-specific HLA-G (histocompatibility antigen class I, G) CD8 T cells in HIV-1 controllers and progressors. Design: We performed an observational cross-sectional cohort...
9.
Chowdhury F, Estrada L, Murray S, Forman J, Farrar J
PLoS One
. 2014 Mar;
9(3):e92187.
PMID: 24642963
CD8+ cytotoxic T lymphocytes (CTLs) play a major role in defense against intracellular pathogens. During development, antigen-presenting cells secrete innate cytokines such as IL-12 and IFN-α, which drive CTL differentiation...
10.
Chowdhury F, Farrar J
JAKSTAT
. 2013 Sep;
2(1):e23633.
PMID: 24058798
STAT2 is unique among the STAT family of transcription factors in that its activation is driven predominantly by only two classes of cell surface receptors: Type I and III interferon...